Invokana (canagliflozin)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) May 2016 WARNINGS AND PRECAUTIONS Acute Kidney Injury and Impairment in Renal Function INVOKANA causes intravascular volume...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts